Cargando…

Recurrent Cellulitis: Who is at Risk and How Effective is Antibiotic Prophylaxis?

Recurrent cellulitis following successful treatment is common and prevention should be a major component in the management of cellulitis. Conditions that increase the risk of recurrence include chronic edema, venous disease, dermatomycosis and obesity. These risk factors should be actively managed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Bin S, Dotel, Ravindra, Ngian, Vincent Jiu Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379124/
https://www.ncbi.nlm.nih.gov/pubmed/35983462
http://dx.doi.org/10.2147/IJGM.S326459
_version_ 1784768624875012096
author Ong, Bin S
Dotel, Ravindra
Ngian, Vincent Jiu Jong
author_facet Ong, Bin S
Dotel, Ravindra
Ngian, Vincent Jiu Jong
author_sort Ong, Bin S
collection PubMed
description Recurrent cellulitis following successful treatment is common and prevention should be a major component in the management of cellulitis. Conditions that increase the risk of recurrence include chronic edema, venous disease, dermatomycosis and obesity. These risk factors should be actively managed as further episodes of cellulitis increases the risk of recurrence. The role of non-antibiotic measures is important and should be first-line in prevention. Antibiotic prophylaxis is effective, but its role is limited to non-purulent cellulitis where risk factors are appropriately managed.
format Online
Article
Text
id pubmed-9379124
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93791242022-08-17 Recurrent Cellulitis: Who is at Risk and How Effective is Antibiotic Prophylaxis? Ong, Bin S Dotel, Ravindra Ngian, Vincent Jiu Jong Int J Gen Med Review Recurrent cellulitis following successful treatment is common and prevention should be a major component in the management of cellulitis. Conditions that increase the risk of recurrence include chronic edema, venous disease, dermatomycosis and obesity. These risk factors should be actively managed as further episodes of cellulitis increases the risk of recurrence. The role of non-antibiotic measures is important and should be first-line in prevention. Antibiotic prophylaxis is effective, but its role is limited to non-purulent cellulitis where risk factors are appropriately managed. Dove 2022-08-10 /pmc/articles/PMC9379124/ /pubmed/35983462 http://dx.doi.org/10.2147/IJGM.S326459 Text en © 2022 Ong et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Ong, Bin S
Dotel, Ravindra
Ngian, Vincent Jiu Jong
Recurrent Cellulitis: Who is at Risk and How Effective is Antibiotic Prophylaxis?
title Recurrent Cellulitis: Who is at Risk and How Effective is Antibiotic Prophylaxis?
title_full Recurrent Cellulitis: Who is at Risk and How Effective is Antibiotic Prophylaxis?
title_fullStr Recurrent Cellulitis: Who is at Risk and How Effective is Antibiotic Prophylaxis?
title_full_unstemmed Recurrent Cellulitis: Who is at Risk and How Effective is Antibiotic Prophylaxis?
title_short Recurrent Cellulitis: Who is at Risk and How Effective is Antibiotic Prophylaxis?
title_sort recurrent cellulitis: who is at risk and how effective is antibiotic prophylaxis?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379124/
https://www.ncbi.nlm.nih.gov/pubmed/35983462
http://dx.doi.org/10.2147/IJGM.S326459
work_keys_str_mv AT ongbins recurrentcellulitiswhoisatriskandhoweffectiveisantibioticprophylaxis
AT dotelravindra recurrentcellulitiswhoisatriskandhoweffectiveisantibioticprophylaxis
AT ngianvincentjiujong recurrentcellulitiswhoisatriskandhoweffectiveisantibioticprophylaxis